U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6594165941Physical Therapy Management in Degenerative Lumbar Diseases and OsteoporosisRecruitingNo Results AvailableLow Back Painhttps://ClinicalTrials.gov/show/NCT01703403
6594265942Biomarker Directed Treatment in Metastatic Colorectal CancerRecruitingNo Results AvailableMetastatic Colorectal CancerDrug: FOLFIRI + Cetuximab|Drug: modifiedFOLFOX6 + Cetuximabhttps://ClinicalTrials.gov/show/NCT01703390
6594365943Effect of Constraining Joint Motions on Postural ControlRecruitingNo Results AvailableHealthy Adultshttps://ClinicalTrials.gov/show/NCT01703377
6594465944Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLLActive, not recruitingNo Results AvailableCLL|Chronic Lymphocytic LeukemiaDrug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT01703364
6594565945Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS LobectomyRecruitingNo Results AvailableLung Cancer,|Postoperative PainDrug: 0.5% ropivacaine|Drug: Fentanyl 500mcg + acupan 160mg + nasea 0.6mghttps://ClinicalTrials.gov/show/NCT01703351
6594665946Clinical and Biomechanics Research in Core Muscles After Lumbar Fusion SurgeryRecruitingNo Results AvailableLumbar Fusion|Lumbar Spinal Fusion Surgeryhttps://ClinicalTrials.gov/show/NCT01703338
6594765947Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic NailsCompletedNo Results AvailablePsoriatic NailsDrug: 0.1% triamcinolone , 0.05% clobetasol propionate ointmenthttps://ClinicalTrials.gov/show/NCT01703325
6594865948A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic AsthmaCompletedNo Results AvailableAllergic AsthmaDrug: QGE031|Drug: omalizumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT01703312
6594965949Emergence of Resistance in Intestinal Microflora During Carbapenem TreatmentsCompletedNo Results AvailableCarbapenem-induced Resistancehttps://ClinicalTrials.gov/show/NCT01703299
6595065950Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Placebo|Drug: Linagliptin|Drug: Placebo|Drug: Placebo|Drug: Placebo|Drug: Glimepiridehttps://ClinicalTrials.gov/show/NCT01703286
6595165951Low-level Intervention for Adolescents With Extreme ObesityCompletedNo Results AvailableObesity|Extreme ObesityBehavioral: manual based low key group intervention (innovation)|Behavioral: standardized, manual based routine carehttps://ClinicalTrials.gov/show/NCT01703273
6595265952Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitisTerminatedNo Results AvailableNonalcoholic SteatohapatitisDrug: Roflumilast|Drug: Pioglitazone|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01703260
6595365953Ganglionated Plexi Ablation Combined With Pulmonary Vein IsolationCompletedNo Results AvailablePersistent Atrial FibrillationProcedure: Pulmonary vein isolation|Procedure: Ganglionated plexi ablation|Procedure: Linear Lesion Ablationhttps://ClinicalTrials.gov/show/NCT01703247
6595465954FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric PatientsCompletedNo Results AvailableProteinuria|Diabetic Nephropathy|Chronic Kidney DiseaseDrug: Ramiprilhttps://ClinicalTrials.gov/show/NCT01703234
6595565955MK-3102 Phase III Clinical Trial - Placebo- and Sitagliptin-controlled Monotherapy Study in Japanese Participants With Type 2 Diabetes Mellitis (MK-3102-020)CompletedNo Results AvailableType 2 Diabetes MellitusDrug: MK-3102|Drug: Sitagliptin|Drug: Placebo to MK-3102|Drug: Placebo to sitagliptinhttps://ClinicalTrials.gov/show/NCT01703221
6595665956A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)Active, not recruitingNo Results AvailableType 2 Diabetes MellitusDrug: Omarigliptin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01703208
6595765957Magnetic Resonance Imaging of Gynecologic Malignancies Involving the VaginaRecruitingNo Results AvailableVaginal CancerProcedure: Magnetic Resonance Imaging (MRI)|Procedure: Diffusion Weighted Magnetic Resonance Imaging (DWMR)https://ClinicalTrials.gov/show/NCT01703195
6595865958Transcutaneous Oximetry, Transcutaneous Carbon Dioxide and Supplemental Oxygen Therapy in Lower Limb AmputationsTerminatedNo Results AvailableAmputation Woundhttps://ClinicalTrials.gov/show/NCT01703182
6595965959Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic AnemiaRecruitingNo Results AvailableSevere Aplastic Anemia|Very Severe Aplastic Anemia|Moderate Aplastic AnemiaDrug: Eltrombopaghttps://ClinicalTrials.gov/show/NCT01703169
6596065960Low Risk Acute Coronary SyndromeCompletedNo Results AvailableLow Risk Acute Coronary SyndromeProcedure: Stress Test|Procedure: No Stress Testhttps://ClinicalTrials.gov/show/NCT01703156
6596165961Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial EpilepsyCompletedNo Results AvailableEpilepsyProcedure: Laser ablationhttps://ClinicalTrials.gov/show/NCT01703143
6596265962Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical AnesthesiaRecruitingNo Results AvailableShoulder PainProcedure: Dose of of ropivacaine 0.75% used in block procedurehttps://ClinicalTrials.gov/show/NCT01703130
6596365963Riluzole in Mild Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's DiseaseDrug: Riluzole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01703117
6596465964The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell AnemiaCompletedNo Results AvailableSickle Cell AnemiaDrug: Paludrine + Folic Acid|Dietary Supplement: Paludrine + Folic Acid + Jobelynhttps://ClinicalTrials.gov/show/NCT01703104
6596565965A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon-small Cell Lung Cancer MetastaticDrug: Ramucirumab|Drug: Placebo|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT01703091
6596665966Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic KeratosisCompletedNo Results AvailableActinic KeratosisDrug: Ingenol once daily for two consecutive dayshttps://ClinicalTrials.gov/show/NCT01703078
6596765967Cabozantinib in Treating Men With Castration-Resistant Prostate CancerRecruitingNo Results AvailableAdenocarcinoma of the Prostate|Castration-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate CancerDrug: cabozantinib-s-malate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01703065
6596865968Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)CompletedNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Drug: CHF 6001 SD or placebo|Drug: CHF 6001 MD or placebohttps://ClinicalTrials.gov/show/NCT01703052
6596965969Riluzole Augmentation Pilot in Depression (RAPID) TrialRecruitingNo Results AvailableMajor Depressive DisorderDrug: Riluzole|Drug: Sertraline|Other: placebohttps://ClinicalTrials.gov/show/NCT01703039
6597065970Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic MassesCompletedNo Results AvailablePancreatic Cancerhttps://ClinicalTrials.gov/show/NCT01703026

* Görseller ve İçerik tekif hakkına sahip olabilir